Kenneth Aldape
0000-0001-5119-7550
Publication & Citation Trends
Publications
0 total
Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial. OA
Cited by 3
Semantic Scholar
Establishing the Utility of Deep Learning for H&E-Based Meningioma Molecular Classification and Outcome Prediction
Cited by 0
Semantic Scholar
374 TERT Expression Predicts Progression-Free Survival in Meningiomas Independent of TERT Promoter Mutation
Cited by 0
Semantic Scholar
DNA methylation profiling in central nervous system tumours
Cited by 0
Semantic Scholar
Molecular classification of radiation-induced meningiomas.
Cited by 0
Semantic Scholar
Identifying clinically relevant cell state interactions in the tumor microenvironment of IDH-mutant gliomas using CSI-TME OA
Cited by 0
Semantic Scholar
cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant Gliomas. OA
Cited by 6
Semantic Scholar
BIOM-08. CHROMOSOME 1P LOSS AND 1Q GAIN ARE HIGHLY PROGNOSTIC AND CAN INFORM WHO GRADING OF MENINGIOMA
Cited by 0
Semantic Scholar
Research Topics
Glioma Diagnosis and Treatment
(530)
Cancer Genomics and Diagnostics
(139)
Brain Metastases and Treatment
(129)
Meningioma and schwannoma management
(121)
Epigenetics and DNA Methylation
(106)
Affiliations
Kanazawa University
Florida State University
University of Notre Dame
Northwestern University
Ontario Institute for Cancer Research
External Profiles
Continue on JournalsHub
Put what you just read into practice with these free tools.